• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 454784 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1414792344 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1414792344 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Investors look to Lighten Up on Shares of Inovio Biomedical, Shares Down 23.1% (INO)

Published on Thu, 03/07/2013 - 11:23
By Peter Chu

Inovio Biomedical (AMEX:INO) is one of today's worst performing penny stocks, down 23.1% to $0.53 on 3.5x average daily volume. Thus far today, Inovio Biomedical has traded 5.2 million shares, vs. average volume of 1.5 million shares per day. The stock has underperformed the Dow (-23.1% to the Dow's 0.3%) and underperformed the S&P 500 (-23.1% to the S&P's 0.1%) during today's trading.

Potential upside of 239.4% exists for Inovio Biomedical, based on a current level of $0.53 and analysts' average consensus price target of $1.80. Inovio Biomedical shares should first meet resistance at the 200-day moving average (MA) of $0.57 and find additional resistance at the 50-day MA of $0.66.

In the past 52 weeks, Inovio Biomedical share prices have been bracketed by a low of $0.38 and a high of $0.83 and are now at $0.53, 40% above that low price. The 200-day and 50-day moving averages have moved 0.55% higher and 1.54% higher over the past week, respectively.

Inovio Biomedical Corporation is focused on developing multiple DNA-based immunotherapies. The Company develops applications of electroporation using brief, controlled electrical pulses to increase cellular uptake of a useful biopharmaceutical.

By Peter Chu
pchu@fnno.com

Latest News from FNNO

Recent 52-Week High Exceeded in Shares o...

SCANA (NYSE:SCG) traded today at a new 52-week high of $55.05. This new high was reach ...

Shares of SBA Communications Have Risen ...

Shares of SBA Communications (NASDAQ:SBAC) traded today at $116.05, breaking its 52-wee ...

Shares of Sanmina-SCI Rise to a New 52-W...

Sanmina-SCI (NASDAQ:SANM) traded today at a new 52-week high of $25.25. So far today a ...

Shares of Seabridge Gold Fall Below Prev...

Shares of Seabridge Gold (AMEX:SA) traded today at $6.21, breaking its 52-week low. Th ...

Shares of Raytheon Rise Above Previous 5...

Raytheon (NYSE:RTN) traded today at a new 52-week high of $104.97. So far today approx ...

Ramco-Gershenson Properties Trust Looks ...

Ramco-Gershenson Properties Trust (NYSE:RPT) traded at a new 52-week high today of $17. ...

Ross Stores Looks to Continue to Trade A...

Shares of Ross Stores (NASDAQ:ROST) traded today at $82.00, breaking its 52-week high. ...

Roper Industries: 52-Week High Recently ...

Roper Industries (NYSE:ROP) traded at a new 52-week high today of $159.19. Approximate ...